Assembly Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Assembly Biosciences (ASMB).

Price Target Range — 7 Quarters

Analyst Consensus — 6 Analysts

1S.Buy

5Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$45Upside to Avg. PT+118.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 1, 2026	Mizuho	Salim Syed	PT Cut	Outperform	$53→$45
Sep 1, 2026	UBS	Ashwani Verma	Initiate	Buy	$52
Aug 18, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Jun 15, 2026	Mizuho	Salim Syed	PT Raise	Outperform	$40→$45
May 28, 2026	Guggenheim	Vamil Divan	Maintained	Buy	$43
May 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Apr 6, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$39→$43
Mar 26, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Dec 22, 2025	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Nov 20, 2025	Mizuho	Salim Syed	PT Raise	Outperform	$29→$40
Oct 14, 2025	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Sep 24, 2025	JMP Securities	Roy Buchanan	Initiate	Market Outperform	$38
Sep 8, 2025	Guggenheim	Vamil Divan	PT Raise	Buy	$31→$39
Aug 18, 2025	HC Wainwright & Co.	Patrick Trucchio	Assumes	Buy	$50
Mar 25, 2025	Guggenheim	Vamil Divan	Initiate	Buy	$31
Mar 24, 2025	HC Wainwright & Co.	Ed Arce	Maintained	Neutral	—
Dec 27, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Neutral	—
Sep 24, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Neutral	—
Sep 20, 2024	Jefferies	Dennis Ding	Upgrade	Hold→Buy	$2→$35
Jun 20, 2024	HC Wainwright & Co.	Ed Arce	Maintained	Neutral	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Mizuho Maintains Outperform on Assembly Biosciences, Lowers Price Target to $45

Mizuho analyst Salim Syed maintains Assembly Biosciences (NASDAQ:ASMB) with a Outperform and lowers the price target from $53 to $45.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Assembly Biosciences (NASDAQ:ASMB) with a Buy and maintains $50 price target.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $45

Mizuho analyst Salim Syed maintains Assembly Biosciences (NASDAQ:ASMB) with a Outperform and raises the price target from $40 to $45.

Benzinga Newsdesk

PRO
Guggenheim Reiterates Buy on Assembly Biosciences, Maintains $43 Price Target

Guggenheim analyst Vamil Divan reiterates Assembly Biosciences (NASDAQ:ASMB) with a Buy and maintains $43 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Assembly Biosciences (NASDAQ:ASMB) with a Buy and maintains $50 price target.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Assembly Biosciences, Raises Price Target to $43

Guggenheim analyst Vamil Divan maintains Assembly Biosciences (NASDAQ:ASMB) with a Buy and raises the price target from $39 to $43.

Benzinga Newsdesk

Assembly Biosciences Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Assembly Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Mizuho Maintains Outperform on Assembly Biosciences, Lowers Price Target to $45

PRO
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

PRO
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $45

PRO
Guggenheim Reiterates Buy on Assembly Biosciences, Maintains $43 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

PRO
Guggenheim Maintains Buy on Assembly Biosciences, Raises Price Target to $43

People Also Watch

People Also Watch

Assembly Biosciences Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Assembly Biosciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMizuho Maintains Outperform on Assembly Biosciences, Lowers Price Target to $45

PROHC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

PROMizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $45

PROGuggenheim Reiterates Buy on Assembly Biosciences, Maintains $43 Price Target

PROHC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

PROGuggenheim Maintains Buy on Assembly Biosciences, Raises Price Target to $43

People Also Watch

People Also Watch

PRO
Mizuho Maintains Outperform on Assembly Biosciences, Lowers Price Target to $45

PRO
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

PRO
Mizuho Maintains Outperform on Assembly Biosciences, Raises Price Target to $45

PRO
Guggenheim Reiterates Buy on Assembly Biosciences, Maintains $43 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target

PRO
Guggenheim Maintains Buy on Assembly Biosciences, Raises Price Target to $43